Files in this item
Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation
Item metadata
dc.contributor.author | Sajic, Marija | |
dc.contributor.author | Hunt, David P.J. | |
dc.contributor.author | Lee, Woojin | |
dc.contributor.author | Compston, D. Alastair S. | |
dc.contributor.author | Schweimer, Judith V. | |
dc.contributor.author | Gregson, Norman A. | |
dc.contributor.author | Chandran, Siddharthan | |
dc.contributor.author | Smith, Kenneth J. | |
dc.date.accessioned | 2021-07-16T11:30:24Z | |
dc.date.available | 2021-07-16T11:30:24Z | |
dc.date.issued | 2012-02-16 | |
dc.identifier.citation | Sajic , M , Hunt , D P J , Lee , W , Compston , D A S , Schweimer , J V , Gregson , N A , Chandran , S & Smith , K J 2012 , ' Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation ' , PLoS ONE , vol. 7 , no. 2 , e30708 . https://doi.org/10.1371/journal.pone.0030708 | en |
dc.identifier.issn | 1932-6203 | |
dc.identifier.other | PURE: 275054070 | |
dc.identifier.other | PURE UUID: 065f362b-327c-4698-b4d8-30f4364440a0 | |
dc.identifier.other | Scopus: 84863171061 | |
dc.identifier.other | PubMed: 22359549 | |
dc.identifier.other | ORCID: /0000-0002-5968-3534/work/108119023 | |
dc.identifier.uri | https://hdl.handle.net/10023/23592 | |
dc.description | DH is funded by a Brain entrance scholarship (Guarantors of Brain) and by the Wellcome Trust. KJS is funded by the Medical Research Council, United Kingdom, the Multiple Sclerosis Society of Great Britian & Northern Ireland, the European Union (FP6 NeuroproMiSe) and the Brain Research Trust. SC is supported by the National Institute for Health Research Biomedical Research. | en |
dc.description.abstract | Mesenchymal stem cells have been demonstrated to ameliorate experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, prompting clinical trials in multiple sclerosis which are currently ongoing. An important question is whether this therapeutic effect generalises to other autoimmune neurological diseases. We performed two trials of efficacy of MSCs in experimental autoimmune neuritis (EAN) in Lewis (LEW/Han MHsd) rats, a model of human autoimmune inflammatory neuropathies. No differences between the groups were found in clinical, histological or electrophysiological outcome measures. This was despite the ability of mesenchymal stem cells to inhibit proliferation of CD4+ T-cells in vitro. Therefore the efficacy of MSCs observed in autoimmune CNS demyelination models do not necessarily generalise to the treatment of other forms of neurological autoimmunity. | |
dc.language.iso | eng | |
dc.relation.ispartof | PLoS ONE | en |
dc.rights | Copyright: © 2012 Sajic et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en |
dc.subject | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | en |
dc.subject | Biochemistry, Genetics and Molecular Biology(all) | en |
dc.subject | Agricultural and Biological Sciences(all) | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | RC0321 | en |
dc.title | Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation | en |
dc.type | Journal article | en |
dc.description.version | Publisher PDF | en |
dc.contributor.institution | University of St Andrews. School of Psychology and Neuroscience | en |
dc.identifier.doi | https://doi.org/10.1371/journal.pone.0030708 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.